These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11144053)

  • 21. Measurement of inspiratory flow in children with acute asthma.
    Bentur L; Mansour Y; Hamzani Y; Beck R; Elias N; Amirav I
    Pediatr Pulmonol; 2004 Oct; 38(4):304-7. PubMed ID: 15334507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The evaluation of the relationship between the residual fluticasone propionate dry powder after inhalation and maximum peak inspiratory flow].
    Ohbayashi H; Yamase H
    Arerugi; 2002 Jul; 51(7):544-51. PubMed ID: 12201167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
    Engel T; Heinig JH; Madsen F; Nikander K
    Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of inspiratory flow for the selection of the inhalation treatment device for asthma and COPD].
    Plavec D; Gluncić TJ; Gudelj I; Mise K
    Lijec Vjesn; 2012; 134(3-4):84-9. PubMed ID: 22768682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peak inspiratory flow through Turbuhaler in acute asthma.
    Brown PH; Ning AC; Greening AP; McLean A; Crompton GK
    Eur Respir J; 1995 Nov; 8(11):1940-1. PubMed ID: 8620966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
    Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
    Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers.
    Broeders ME; Molema J; Vermue NA; Folgering HT
    Eur Respir J; 2001 Nov; 18(5):780-3. PubMed ID: 11757627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of a dry powder inhaler and metered dose inhaler with spacer in management of children with asthma.
    Singh M; Kumar L
    Indian Pediatr; 2001 Jan; 38(1):24-8. PubMed ID: 11175930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective evaluation of the adequacy of peak inspiratory flow rates and validation of the Turbutester score in asthmatic individuals with "low" peak expiratory flow rates: implications for dry powder inhalers.
    Melamed J; Beaucher W
    J Allergy Clin Immunol; 2003 Mar; 111(3):648-50. PubMed ID: 12642853
    [No Abstract]   [Full Text] [Related]  

  • 33. Novolizer: the new technology for the management of asthma therapy.
    Köhler D
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
    Ige OM; Sogaolu OM
    Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
    Tarsin WY; Pearson SB; Assi KH; Chrystyn H
    Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patients.
    Persson G; Olsson B; Soliman S
    Eur Respir J; 1997 Mar; 10(3):681-4. PubMed ID: 9073005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new breath actuated dry powder inhaler (Auto-Jethaler)].
    Steiss JO; Heckmann M; Jödicke B; Landmann E; Schüler D; Weber K; Pabst J; Lindemann H
    Klin Padiatr; 2007; 219(2):66-9. PubMed ID: 16878285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease.
    Quinet P; Young CA; Héritier F
    Ann Phys Rehabil Med; 2010 Mar; 53(2):69-76. PubMed ID: 20018583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peak inspiratory flow rates attained by asthmatic patients through a dry-powder inhaler of fluticasone propionate].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2001 Jun; 50(6):551-4. PubMed ID: 11517519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.